AMIKACIN SULFATE

Amikacin sulfate shares the same antimicrobial mechanism as amikacin, offering potent bactericidal effects. Clinical uses include severe infections. Side effects include renal impairment, hearing loss, and vestibular toxicity.

SKU: 1ae3302b844a Category: Tag:

Product Description


Mechanism of action

Amikacin sulfate is the sulfate salt of amikacin, providing improved solubility and stability for parenteral formulations. Its antibacterial mechanism is identical to that of amikacin base: irreversible binding to the 30S ribosomal subunit of susceptible bacteria, leading to inhibition of protein synthesis and rapid bactericidal activity.

Benefits and advantages

The sulfate salt form is used in injectable medicinal products for intravenous or intramuscular administration, ensuring reliable dissolution, sterility and shelf-life characteristics. It enables precise dosing in critical care and infectious disease settings where amikacin is selected for its robust activity against resistant Gram- negative organisms.

Side effects and risks

Toxicity, precautions and monitoring requirements are the same as those for amikacin base, including the risks of nephrotoxicity and ototoxicity. Manufacturing must comply with stringent good manufacturing practices, and workers should be protected from exposure to aerosolised or powdered antibiotic material.

Professional use only. Supplied exclusively to licensed manufacturers and healthcare institutions.

Datasheet


Molecular Formula

C22H47N5O21S2

Molecular Weight

781.8 g/mol

CAS Number

39831-55-5

Storage Condition

Store at 20 deg to 25 °C (68 deg to 77 °F); excursions permitted between 15 deg to 30 °C (59 deg to 86 °F)

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

AMIKACIN SULFATE; 39831-55-5; Amikacin sulphate; Arikayce; BB-K8

IUPAC/Chemical Name

(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-2-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-[(2R,3R,4S,5S,6R)-6-(aminomethyl)-3,4,5-trihydroxyoxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide;sulfuric acid

InChl Key

FXKSEJFHKVNEFI-GCZBSULCSA-N

InChl Code

InChI=1S/C22H43N5O13.2H2O4S/c23-2-1-8(29)20(36)27-7-3-6(25)18(39-22-16(34)15(33)13(31)9(4-24)37-22)17(35)19(7)40-21-14(32)11(26)12(30)10(5-28)38-21;2*1-5(2,3)4/h6-19,21-22,28-35H,1-5,23-26H2,(H,27,36);2*(H2,1,2,3,4)/t6-,7+,8-,9+,10+,11-,12+,13+,14+,15-,16+,17-,18+,19-,21+,22+;;/m0../s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/38351;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download